secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-11-25T23:59:59+00:00
Accession:  0001193125-25-294634
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics raises $1.5M in registered direct offering priced at $0.335/share
--------------------------------------------------------------------------------

- Sold 4,477,614 shares at $0.335/share; gross proceeds ~$1.5M before fees.
- Concurrent private placement of 4,477,614 warrants at $0.335 exercise price; exercisable upon stockholder approval.
- H.C. Wainwright placement agent gets 7.0% cash fee, 1.0% management fee, and 313,433 placement agent warrants at $0.4188.
- Net proceeds for working capital and general corporate purposes.
- 30-day lock-up on equity issuances; one-year ban on Variable Rate Transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312525294634/0001193125-25-294634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312525294634/fblg-20251124.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-294634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer